The Jenex Corporation
Jenex is a progressive medical technology company focused on providing consumers with quality dermatological products in the medical device field
Jenex's core philosophy is that clear and healthy skin should not be a privilege for only those who can afford costly procedures and treatments. The Company's breakthrough proprietary thermal therapy technology uses heat and light energy to deliver effective, non-invasive and pain free skin care.
The Jenex Corporation trades on the NEX (NEX: JEN.H). Jenex holds the trademarks and regulatory approvals for its thermal therapy technology.
Latest News
The Jenex Corporation Announces Board Change; Appointment of Advisory Board, Debt Settlement and Option Grants
2018-01-17 8:08 AM ET
Jenex's TherOZap(TM) Technology Indicates Effectiveness in Inhibiting Zika Virus After Pre-Clinical Study
2018-01-08 4:57 PM ET
The Jenex Corporation Announces Graduation to the TSX Venture, Update on Chinese Global Financial Forum and Proposed Acquisition
2017-12-12 9:29 AM ET
The Jenex Corporation Announces Completion of Debt Settlement, Files TherOZap(TM) Device Patent and Presents at Chinese Global Financial Forum
2017-12-04 9:23 AM ET
The Jenex Corporation Announces AGM Results and Submits Application to Graduate to TSXV
2017-11-23 8:46 AM ET
The Jenex Corporation Signs Letter of Intent to Acquire Medical Device Assets
2017-11-02 7:00 AM ET
The Jenex Corporation Reports Promising Initial Results on Zika Virus Testing with TherOZap(TM)
2017-10-12 12:12 PM ET